Brief: Tetra Bio-Pharma Granted Two OTC Drug Identification Numbers By Health Canada
Jan 17 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA GRANTED TWO OTC DRUG IDENTIFICATION
NUMBERS
(DIN) BY HEALTH CANADA
* TETRA BIO PHARMA INC - ANTICIPATES LAUNCHING TERPACAN
PRODUCTS
IN CANADIAN PHARMACY RETAIL OUTLETS BY MID-2020
* TETRA - WILL LAUNCH TERPACAN PRODUCTS INTO AMERICAN,
EUROPEAN
MARKETS IN 2020, ONCE IT RECEIVES FINAL MARKETING AUTHORIZATION
IN THOSE COUNTRIES
Source text for Eikon: ID:nGNX5znQDy
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding